PaThERAS: ERAS Protocols in Thyroid & Parathyroid Surgery
NCT ID: NCT06274970
Last Updated: 2025-01-07
Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
COMPLETED
Clinical Phase
NA
Total Enrollment
96 participants
Study Classification
INTERVENTIONAL
Study Start Date
2023-01-25
Study Completion Date
2024-09-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Enhanced recovery after surgery (ERASP) are evidence-based perioperative protocols devised to expedite postoperative recovery and discharge, decrease surgical stress and costs. However, there is limited data on their use and effectiveness in thyroid and parathyroid surgery. Aim of PaThERAS study is to investigate the clinical benefits and cost-effectiveness of enhanced recovery protocols for the perioperative management in patients undergoing total thyroidectomy for large goiters/ cancers and parathyroidectomy for symptomatic hyperparathyroidism in non-day-care setting.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Implementing Enhanced Recovery After Surgery (ERAS) Protocol in Patients Undergoing Minimal Invasive Esophagectomy
NCT06243887
Esophageal Diseases
Esophagostomy Complication
NOT_YET_RECRUITING
NA
To Assess the Impact of theERAS Consensus on Patients With Endoscopic Pituitary Tumor Surgery
NCT06221020
Enhanced Recovery After Surgery
Pituitary Tumor
Postoperative Complications
RECRUITING
Perioperative ERAS Based Nursing Intervention for Laryngeal Cancer Patients
NCT04174950
Laryngeal Cancer
Nursing
UNKNOWN
NA
Effect of Modified Endotracheal Intubation Protocol Combined With Early Oral Intake on Postoperative Recovery Quality in Thyroid and Parathyroid Surgery
NCT05624463
Thyroid Tumor
COMPLETED
NA
Protective Effect of Intraoperative Parathyroid Gland Auxiliary Recognition System in Thyroid Malignant Tumor Operation
NCT04560426
Parathyroid
Intraoperative Monitoring
Thyroid Cancer
UNKNOWN
NA
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
AIMS AND OBJECTIVES
AIM: To evaluate if Enhanced recovery after surgery protocols; improves peri-operative outcomes in patients undergoing thyroid and parathyroid surgery
OBJECTIVES:
Primary Objective: To compare the rate of hypocalcemia in patients undergoing thyroid and parathyroid surgery implementing Enhanced recovery after surgery protocols vs Conventional peri operative protocols Secondary Objective: To compare the following outcome measures in in patients undergoing thyroid and parathyroid surgery
* length of hospital stay- defined as length of hospital stay from the date of surgery to the date of discharge
* hospital costs
* readmission rate
* postoperative complication rates
MATERIALS AND METHODS
1. Study area: This study will be conducted in the Department of Endocrine and Breast Surgery of Sanjay Gandhi Post Graduate Institute, Lucknow, India
2. Study design: The present study will be a prospective study (Amendment to previous protocol was approved by Institutional Ethics Committee)
* Study group: Prospective cohort
* Control group: Prospective cohort
3. Study Population:
Study group (Group 1)
* Consecutive patients undergoing thyroid and parathyroid surgery in the Dept of Endocrine and Breast Surgery, SGPGI, consenting to participate in the study Control group (Group 2)
* Screening and review of clinical data from the HIS \& patient files
* All age and sex matched patients who underwent similar procedures from Jan 2021-Sept 2024
4. Inclusion Criteria: Patients diagnosed to have ASA Grade 1 and Grade 2 patients with thyroid and/or parathyroid (1° and 2° hyperparathyroidism) disease undergoing the following procedures via open or endoscopic approach
• Total thyroidectomy/Focused parathyroidectomy/BNE with excision of enlarged glands +/- any additional procedure (Eg: Central compartment neck dissection, Lateral neck dissection, Cervical thymectomy etc)
5. Exclusion Criteria: Patients undergoing thyroid and/or parathyroid surgery who
* Undergo hemithyroidectomy
* Refuse to consent to participate in the study in the cohort group
* ASA Grade 3 and Grade 4\* \*Comorbidities of severe nature which may independently impact perioperative hospital stay, complications and outcomes in the study and control group
6. Sample Size
* Primary objective -To compare the LOS in patients implementing enhanced recovery protocols versus conventional perioperative practices in thyroid and parathyroid surgery
* Considering the hospital stay to be 5 days in the control group and 3.5 days in the study group (expecting at least 30% reduction in hospital stay); the standard deviation (SD) being 2.5 days and 1.75 days respectively (assuming 50% SD of mean) at minimum one-sided Confidence interval and 95% Power of study- the study requires 44 patients each in the control group and the intervention group
* Sample size was calculated using software PASS 16
7. Study period: Jan 2023- to Sept 2024
METHODOLOGY This study is being undertaken after approval by the Institutional Ethics committee. This is a prospective study on all patients undergoing thyroid and/or parathyroid surgery who meet the inclusion criteria admitted in the Department of Endocrine Surgery ward, SGPGI, Lucknow. Each patient in the study will be identified using stickers on their file and OPD booklet/card as SGPGI Endocrine Surgery ERASP patients
Selection of subjects
Outcome measures: Those patients diagnosed as having either benign or malignant thyroid and/or parathyroid disease will be enrolled after taking an informed consent. In patients implementing enhanced recovery protocols versus conventional perioperative practices the following outcomes will be compared:
* The length hospital of stay- Date of surgery to date of discharge = no. of days from date of surgery to date of discharge
* Hospital costs- Absolute Billing Amount including hospital stay rental, investigations, medications \& consumables, and surgical fees (minus) Preoperative stay room rent charges
* Postoperative complication rates:
* Hypocalcemia- defined as corrected S. Calcium levels \<8.0mg/dl on Post operative day (POD) 1, POD2, POD7-10
* Surgical site infection- Incisional infection within 30 days after surgery and at least one of the following-
* Purulent drainage, with/without lab confirmation from the superficial incision
* Organisms isolated from aseptically obtained culture fluid or tissue from the superficial incision
* At least one of the following signs or symptoms of infection pain or tenderness, localised swelling, erythema, heat and superficial incision is deliberately opened by the surgeon in a culture negative wound
* Seroma- Accumulation of clear fluid in a tissue or body cavity (will be assessed after drain removal)
* Hematoma- Accumulation of blood in a tissue or body cavity (will be assessed daily until discharge)
* Pain - Measured on Numeric Pain Rating Scale daily until discharge
* Readmission rate- Number of readmissions after discharge The steps followed in the Enhanced recovery protocol were based on adaptations from recommendations by the ERAS society guidelines on head and neck surgery with free flap reconstruction and literature including meta-analyses and systematic reviews as well as randomized controlled trials wherever possible. In the absence of high level data, case series and nonrandomized studies, ATA statements in thyroid and parathyroid surgeries were considered. These recommendations were adapted and modified to make an Institutional Enhanced recovery protocol to cater to the Indian/South Asian demography. Critical team members include the OPD team, operating surgeon, OT team, anesthesiologist, and ward team and ward nursing staff.
Enhanced recovery Protocol Recommendation
Preoperative Considerations Preadmission education- All patients undergoing thyroid and parathyroid surgery will be counselled by a study team member and handed over the study patient information sheet for all information on what to expect before and after surgery
Perioperative nutritional care- All patients undergoing thyroid and parathyroid surgery should undergo preoperative nutritional assessment Grading of Nutritional Status of the patient (BMI) in kg/m2
Peri operative Calcium and Vitamin D supplementation-The role for perioperative vitamin D supplementation in preventing symptoms has been studied at length and shown to be beneficial. All Patients with preoperative Vitamin D levels \<45nmol/L will be administered loading dose of Cholecalciferol 60k IU/gm for 5 days followed by once a month. Post operatively patients will be prophylactically started on 2g of oral Calcium carbonate tablets, Calcitriol supplementation +/- Parenteral Calcium supplementation only if symptomatic for hypocalcemia or pre-tetany (Trousseau's sign /Chovstek's sign positive)
Preoperative fasting should be minimized Prior to anaesthesia -Clear fluids should be permitted for up to 2 hours and solids for up to 6 hours. Carbohydrate loading clear drink 180ml (180ml= 1glass) administered to the patient at 6:00 AM in the morning of surgery along with medicines as prescribed by the Anaesthesiologist Oral diet is the first choice for all patients tolerating it Nutrition interventions should be developed in consultation with the multidisciplinary team and individualized according to nutritional status and surgical procedure.
Antibiotic prophylaxis- Perioperative antibiotics are not indicated for short clean procedures.
Single dose prophylactic broad spectrum antibiotic is administer intravenously at the time of anesthesia induction/ within 1 hour of incision. Dose is repeated if operative time exceeds 4 hours.
Choice of antibiotic- 6-monthly rotational/ alternating practice, as per Hospital infection control committee policy is used. Inj. Amoxycillin 1g + Potassium Clavulanate 200mg (1.2gm) OR Inj. Cefuroxime 1.5gms is administered. In patients with hypersensitivity to either of these, an appropriate substitute e.g. Fluroquinolones like Inj. Ciprofloxacin 400mg is administered.
Postoperative nausea and vomiting prophylaxis- Patients undergoing thyroid and parathyroid surgery should receive preoperative medications to prevent postoperative nausea and/or vomiting.
Tab Pantoprazole 40mg HS and morning of surgery - All ASA Grade 1 and 2 patients are to take their premedication with 1 glass (180 ml) of Carbohydrate loading clear drink at 6:00 AM in the morning of surgery
Pre anaesthetic medications- Patients should receive short acting anxiolytics, given intravenously and titrated to required effect. Longer acting anxiolytics and opioids should be avoided.
Tab. Alprazolam 0.25mg will be given HS and on the morning of surgery
Skin preparation Chlorhexidine bath on the night prior to and morning of surgery On table part preparation with Chlorhexidine 4% solution/ Povidone-Iodine 10% solution. Prep must be allowed to air dry (minimum 3 minutes) before draping and incision
Operative Considerations Preventing hypothermia Normothermia should be maintained intraoperatively. Temperature monitoring is necessary to ensure normothermia is maintained.
Patient adequately covered after placement of ECG leads (use warmer) Warmer used Warm Fluids used at ALL time Head adequately covered (especially in children) Hot line used wherever appropriate Always aim for \>36 degrees C temperature
Perioperative fluid management- Fluids should be managed in a goal-directed manner, avoiding over and under hydration. No fluids should be administered in preop room. Discontinue IV fluids once patient can tolerate orally \>500ml or 4-6 hours post extubation
Intra operative Nerve monitoring (IONM)- Laryngeal nerve monitoring will be used as per operating surgeon's discretion Long-acting neuro muscular blockade should be avoided if IONM is being used
Dressings and drain use- Pressure dressings do not prevent postoperative hematoma, and may obscure visualization of a hematoma. Several randomized prospective studies have shown that the use of a drain after uncomplicated total thyroidectomy, lobectomy, and subtotal thyroidectomy likewise does not reduce the rate of postoperative bleeding Patient will be discharged with drain once there are no signs of bleeding in the drain or after drain removal if drain out put \<20ml/day
Post operative Considerations Pain management Opioid-sparing, multimodal analgesia, utilizing NSAIDs and paracetamol, are preferred Pain will be assessed using Numeric Pain Rating Scale Inj Paracetamol 1gm iv TDS will be administered until the patient is able to tolerate orally Once the patient is orally allowed -Tab Paracetamol 650mg po TDS will be administered if pain 0-3-mild on Numeric Pain Rating Scale. If Pain on Numeric Pain Rating Scale \>/= 4 SOS NSAIDS will be added
Postoperative mobilization- Early mobilization, within the first 24 hours of surgery is recommended
Urinary catheterization- Urinary catheters are ordinarily inserted only if anticipated duration of surgery is \>4 hours. Urinary catheters should be removed as soon as the patient is able to void, ideally less than24 hours after completion of surgery
Postoperative pulmonary physical therapy-Pulmonary physical therapy should be initiated as early as possible after surgery to avoid pulmonary complications.
Head of bed elevation to 30 degrees Steam Inhalation 5 mins thrice daily Incentive spirometry 15 repetitions every 2 hours when the patient is awake Chest Physiotherapy - Attendant/nurse/doctor using cupped hands, Thumping/percussion of posterior lung fields for 5 mins thrice daily
AIM: To evaluate if Enhanced recovery after surgery protocols; improves peri-operative outcomes in patients undergoing thyroid and parathyroid surgery
OBJECTIVES:
Primary Objective: To compare the rate of hypocalcemia in patients undergoing thyroid and parathyroid surgery implementing Enhanced recovery after surgery protocols vs Conventional peri operative protocols Secondary Objective: To compare the following outcome measures in in patients undergoing thyroid and parathyroid surgery
* length of hospital stay- defined as length of hospital stay from the date of surgery to the date of discharge
* hospital costs
* readmission rate
* postoperative complication rates
MATERIALS AND METHODS
1. Study area: This study will be conducted in the Department of Endocrine and Breast Surgery of Sanjay Gandhi Post Graduate Institute, Lucknow, India
2. Study design: The present study will be a prospective study (Amendment to previous protocol was approved by Institutional Ethics Committee)
* Study group: Prospective cohort
* Control group: Prospective cohort
3. Study Population:
Study group (Group 1)
* Consecutive patients undergoing thyroid and parathyroid surgery in the Dept of Endocrine and Breast Surgery, SGPGI, consenting to participate in the study Control group (Group 2)
* Screening and review of clinical data from the HIS \& patient files
* All age and sex matched patients who underwent similar procedures from Jan 2021-Sept 2024
4. Inclusion Criteria: Patients diagnosed to have ASA Grade 1 and Grade 2 patients with thyroid and/or parathyroid (1° and 2° hyperparathyroidism) disease undergoing the following procedures via open or endoscopic approach
• Total thyroidectomy/Focused parathyroidectomy/BNE with excision of enlarged glands +/- any additional procedure (Eg: Central compartment neck dissection, Lateral neck dissection, Cervical thymectomy etc)
5. Exclusion Criteria: Patients undergoing thyroid and/or parathyroid surgery who
* Undergo hemithyroidectomy
* Refuse to consent to participate in the study in the cohort group
* ASA Grade 3 and Grade 4\* \*Comorbidities of severe nature which may independently impact perioperative hospital stay, complications and outcomes in the study and control group
6. Sample Size
* Primary objective -To compare the LOS in patients implementing enhanced recovery protocols versus conventional perioperative practices in thyroid and parathyroid surgery
* Considering the hospital stay to be 5 days in the control group and 3.5 days in the study group (expecting at least 30% reduction in hospital stay); the standard deviation (SD) being 2.5 days and 1.75 days respectively (assuming 50% SD of mean) at minimum one-sided Confidence interval and 95% Power of study- the study requires 44 patients each in the control group and the intervention group
* Sample size was calculated using software PASS 16
7. Study period: Jan 2023- to Sept 2024
METHODOLOGY This study is being undertaken after approval by the Institutional Ethics committee. This is a prospective study on all patients undergoing thyroid and/or parathyroid surgery who meet the inclusion criteria admitted in the Department of Endocrine Surgery ward, SGPGI, Lucknow. Each patient in the study will be identified using stickers on their file and OPD booklet/card as SGPGI Endocrine Surgery ERASP patients
Selection of subjects
Outcome measures: Those patients diagnosed as having either benign or malignant thyroid and/or parathyroid disease will be enrolled after taking an informed consent. In patients implementing enhanced recovery protocols versus conventional perioperative practices the following outcomes will be compared:
* The length hospital of stay- Date of surgery to date of discharge = no. of days from date of surgery to date of discharge
* Hospital costs- Absolute Billing Amount including hospital stay rental, investigations, medications \& consumables, and surgical fees (minus) Preoperative stay room rent charges
* Postoperative complication rates:
* Hypocalcemia- defined as corrected S. Calcium levels \<8.0mg/dl on Post operative day (POD) 1, POD2, POD7-10
* Surgical site infection- Incisional infection within 30 days after surgery and at least one of the following-
* Purulent drainage, with/without lab confirmation from the superficial incision
* Organisms isolated from aseptically obtained culture fluid or tissue from the superficial incision
* At least one of the following signs or symptoms of infection pain or tenderness, localised swelling, erythema, heat and superficial incision is deliberately opened by the surgeon in a culture negative wound
* Seroma- Accumulation of clear fluid in a tissue or body cavity (will be assessed after drain removal)
* Hematoma- Accumulation of blood in a tissue or body cavity (will be assessed daily until discharge)
* Pain - Measured on Numeric Pain Rating Scale daily until discharge
* Readmission rate- Number of readmissions after discharge The steps followed in the Enhanced recovery protocol were based on adaptations from recommendations by the ERAS society guidelines on head and neck surgery with free flap reconstruction and literature including meta-analyses and systematic reviews as well as randomized controlled trials wherever possible. In the absence of high level data, case series and nonrandomized studies, ATA statements in thyroid and parathyroid surgeries were considered. These recommendations were adapted and modified to make an Institutional Enhanced recovery protocol to cater to the Indian/South Asian demography. Critical team members include the OPD team, operating surgeon, OT team, anesthesiologist, and ward team and ward nursing staff.
Enhanced recovery Protocol Recommendation
Preoperative Considerations Preadmission education- All patients undergoing thyroid and parathyroid surgery will be counselled by a study team member and handed over the study patient information sheet for all information on what to expect before and after surgery
Perioperative nutritional care- All patients undergoing thyroid and parathyroid surgery should undergo preoperative nutritional assessment Grading of Nutritional Status of the patient (BMI) in kg/m2
Peri operative Calcium and Vitamin D supplementation-The role for perioperative vitamin D supplementation in preventing symptoms has been studied at length and shown to be beneficial. All Patients with preoperative Vitamin D levels \<45nmol/L will be administered loading dose of Cholecalciferol 60k IU/gm for 5 days followed by once a month. Post operatively patients will be prophylactically started on 2g of oral Calcium carbonate tablets, Calcitriol supplementation +/- Parenteral Calcium supplementation only if symptomatic for hypocalcemia or pre-tetany (Trousseau's sign /Chovstek's sign positive)
Preoperative fasting should be minimized Prior to anaesthesia -Clear fluids should be permitted for up to 2 hours and solids for up to 6 hours. Carbohydrate loading clear drink 180ml (180ml= 1glass) administered to the patient at 6:00 AM in the morning of surgery along with medicines as prescribed by the Anaesthesiologist Oral diet is the first choice for all patients tolerating it Nutrition interventions should be developed in consultation with the multidisciplinary team and individualized according to nutritional status and surgical procedure.
Antibiotic prophylaxis- Perioperative antibiotics are not indicated for short clean procedures.
Single dose prophylactic broad spectrum antibiotic is administer intravenously at the time of anesthesia induction/ within 1 hour of incision. Dose is repeated if operative time exceeds 4 hours.
Choice of antibiotic- 6-monthly rotational/ alternating practice, as per Hospital infection control committee policy is used. Inj. Amoxycillin 1g + Potassium Clavulanate 200mg (1.2gm) OR Inj. Cefuroxime 1.5gms is administered. In patients with hypersensitivity to either of these, an appropriate substitute e.g. Fluroquinolones like Inj. Ciprofloxacin 400mg is administered.
Postoperative nausea and vomiting prophylaxis- Patients undergoing thyroid and parathyroid surgery should receive preoperative medications to prevent postoperative nausea and/or vomiting.
Tab Pantoprazole 40mg HS and morning of surgery - All ASA Grade 1 and 2 patients are to take their premedication with 1 glass (180 ml) of Carbohydrate loading clear drink at 6:00 AM in the morning of surgery
Pre anaesthetic medications- Patients should receive short acting anxiolytics, given intravenously and titrated to required effect. Longer acting anxiolytics and opioids should be avoided.
Tab. Alprazolam 0.25mg will be given HS and on the morning of surgery
Skin preparation Chlorhexidine bath on the night prior to and morning of surgery On table part preparation with Chlorhexidine 4% solution/ Povidone-Iodine 10% solution. Prep must be allowed to air dry (minimum 3 minutes) before draping and incision
Operative Considerations Preventing hypothermia Normothermia should be maintained intraoperatively. Temperature monitoring is necessary to ensure normothermia is maintained.
Patient adequately covered after placement of ECG leads (use warmer) Warmer used Warm Fluids used at ALL time Head adequately covered (especially in children) Hot line used wherever appropriate Always aim for \>36 degrees C temperature
Perioperative fluid management- Fluids should be managed in a goal-directed manner, avoiding over and under hydration. No fluids should be administered in preop room. Discontinue IV fluids once patient can tolerate orally \>500ml or 4-6 hours post extubation
Intra operative Nerve monitoring (IONM)- Laryngeal nerve monitoring will be used as per operating surgeon's discretion Long-acting neuro muscular blockade should be avoided if IONM is being used
Dressings and drain use- Pressure dressings do not prevent postoperative hematoma, and may obscure visualization of a hematoma. Several randomized prospective studies have shown that the use of a drain after uncomplicated total thyroidectomy, lobectomy, and subtotal thyroidectomy likewise does not reduce the rate of postoperative bleeding Patient will be discharged with drain once there are no signs of bleeding in the drain or after drain removal if drain out put \<20ml/day
Post operative Considerations Pain management Opioid-sparing, multimodal analgesia, utilizing NSAIDs and paracetamol, are preferred Pain will be assessed using Numeric Pain Rating Scale Inj Paracetamol 1gm iv TDS will be administered until the patient is able to tolerate orally Once the patient is orally allowed -Tab Paracetamol 650mg po TDS will be administered if pain 0-3-mild on Numeric Pain Rating Scale. If Pain on Numeric Pain Rating Scale \>/= 4 SOS NSAIDS will be added
Postoperative mobilization- Early mobilization, within the first 24 hours of surgery is recommended
Urinary catheterization- Urinary catheters are ordinarily inserted only if anticipated duration of surgery is \>4 hours. Urinary catheters should be removed as soon as the patient is able to void, ideally less than24 hours after completion of surgery
Postoperative pulmonary physical therapy-Pulmonary physical therapy should be initiated as early as possible after surgery to avoid pulmonary complications.
Head of bed elevation to 30 degrees Steam Inhalation 5 mins thrice daily Incentive spirometry 15 repetitions every 2 hours when the patient is awake Chest Physiotherapy - Attendant/nurse/doctor using cupped hands, Thumping/percussion of posterior lung fields for 5 mins thrice daily
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Thyroid Diseases
Parathyroid Diseases
ERAS
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Allocation Method
NON_RANDOMIZED
Intervention Model
SINGLE_GROUP
Primary Study Purpose
TREATMENT
Blinding Strategy
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ERAS Group
Those patients who follow ERAS protocols preoperatively, intraoperatively and post operatively
Group Type
EXPERIMENTAL
Enhanced recovery protocols
Intervention Type
OTHER
Aforementioned in the detailed description
Conventional Group
Those patients who conventional protocols preoperatively, intraoperatively and post operatively
Group Type
ACTIVE_COMPARATOR
Conventional Protocols
Intervention Type
OTHER
Conventional protocols for non-ERASP group Eg: No preoperative vitamin D and calcium supplementation etc.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Enhanced recovery protocols
Aforementioned in the detailed description
Intervention Type
OTHER
Conventional Protocols
Conventional protocols for non-ERASP group Eg: No preoperative vitamin D and calcium supplementation etc.
Intervention Type
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients diagnosed to have ASA Grade 1 and Grade 2 patients with thyroid and/or parathyroid (1° and 2° hyperparathyroidism) disease undergoing the following procedures via open or endoscopic approach • Total thyroidectomy/Focused parathyroidectomy/BNE with excision of enlarged glands +/- any additional procedure (Eg: Central compartment neck dissection, Lateral neck dissection, Cervical thymectomy etc)
Exclusion Criteria
* Patients undergoing thyroid and/or parathyroid surgery who
* Undergo hemithyroidectomy
* Refuse to consent to participate in the study in the cohort group
* ASA Grade 3 and Grade 4\* \*Comorbidities of severe nature which may independently impact perioperative hospital stay, complications and outcomes in the study and control group
* Undergo hemithyroidectomy
* Refuse to consent to participate in the study in the cohort group
* ASA Grade 3 and Grade 4\* \*Comorbidities of severe nature which may independently impact perioperative hospital stay, complications and outcomes in the study and control group
Minimum Eligible Age
18 Years
Eligible Sex
ALL
Accepts Healthy Volunteers
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sanjay Gandhi Postgraduate Institute of Medical Sciences
OTHER_GOV
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gaurav Agarwal
Professor and Head of Department Endocrine and Breast Surgery
Responsibility Role
PRINCIPAL_INVESTIGATOR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sanjay Gandhi Post Graduate Institute of Medical Sciences
Lucknow, Uttar Pradesh, India
Site Status
Countries
Review the countries where the study has at least one active or historical site.
India
References
Explore related publications, articles, or registry entries linked to this study.
Chorath K, Luu N, Go BC, Moreira A, Rajasekaran K. ERAS Protocols for Thyroid and Parathyroid Surgery: A Systematic Review and Meta-analysis. Otolaryngol Head Neck Surg. 2022 Mar;166(3):425-433. doi: 10.1177/01945998211019671. Epub 2021 Jun 15.
Reference Type
BACKGROUND
Smith TW Jr, Wang X, Singer MA, Godellas CV, Vaince FT. Enhanced recovery after surgery: A clinical review of implementation across multiple surgical subspecialties. Am J Surg. 2020 Mar;219(3):530-534. doi: 10.1016/j.amjsurg.2019.11.009. Epub 2019 Nov 16.
Reference Type
BACKGROUND
Dort JC, Farwell DG, Findlay M, Huber GF, Kerr P, Shea-Budgell MA, Simon C, Uppington J, Zygun D, Ljungqvist O, Harris J. Optimal Perioperative Care in Major Head and Neck Cancer Surgery With Free Flap Reconstruction: A Consensus Review and Recommendations From the Enhanced Recovery After Surgery Society. JAMA Otolaryngol Head Neck Surg. 2017 Mar 1;143(3):292-303. doi: 10.1001/jamaoto.2016.2981.
Reference Type
BACKGROUND
Terris DJ, Snyder S, Carneiro-Pla D, Inabnet WB 3rd, Kandil E, Orloff L, Shindo M, Tufano RP, Tuttle RM, Urken M, Yeh MW; American Thyroid Association Surgical Affairs Committee Writing Task Force. American Thyroid Association statement on outpatient thyroidectomy. Thyroid. 2013 Oct;23(10):1193-202. doi: 10.1089/thy.2013.0049. Epub 2013 Sep 14.
Reference Type
BACKGROUND
Xing T, Hu Y, Wang B, Zhu J. Role of oral calcium supplementation alone or with vitamin D in preventing post-thyroidectomy hypocalcaemia: A meta-analysis. Medicine (Baltimore). 2019 Feb;98(8):e14455. doi: 10.1097/MD.0000000000014455.
Reference Type
BACKGROUND
Khatiwada AS, Harris AS. Use of pre-operative calcium and vitamin D supplementation to prevent post-operative hypocalcaemia in patients undergoing thyroidectomy: a systematic review. J Laryngol Otol. 2021 Jul;135(7):568-573. doi: 10.1017/S0022215121001523. Epub 2021 Jun 14.
Reference Type
BACKGROUND
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-143-Mch-EXP-50
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
Thermal Ablation Versus Parathyroidectomy for Primary Hyperparathyroidism
NCT06708871
NOT_YET_RECRUITING
Effect of Intravenous Magnesium on Postoperative Sore Throat After Thyroidectomy
NCT02826746
COMPLETED
NA
The Recovery Profiles After Robotic or Open Thyroidectomy
NCT03222700
UNKNOWN
A Comparative Study Between Laryngeal Mask Airway and Magensium Sulphate in Attenuating Systemic Stress Response During Emergence of Patients Undergoing Supratentorial Tumours.
NCT03406403
COMPLETED
NA
Near-Infrared Autofluorescence With PTH Test Strip as an SOP of Parathyroid in Thyroid Surgery
NCT05684029
COMPLETED
The Effects on Major Organ Complications on Esophagectomy of New Anesthetic ERAS Strategy: a Prospective Investigation
NCT03176680
UNKNOWN
NA
Parathyroid Reimplantation in Forearm Subcutaneous Tissue During Thyroidectomy: a Simple Way to Avoid Ipoparathyroidism and Evaluate Graft Function
NCT02194920
COMPLETED
Effect of Stellate Ganglion Block on Postoperative Nausea and Vomiting
NCT06371131
UNKNOWN
NA
Ultrasound-Guided Microwave Ablation Vs. Surgery for Low-Risk PapilaryThyroid Carcinoma
NCT06725576
RECRUITING
Safety of Endoscopic Thyroidectomy Via Retro-Auricular Single-Site Approach, Transoral Approach and Transareola
NCT05760690
COMPLETED
NA
Is the Routine Pressure Dressing After Thyroidectomy Necessary?
NCT00400465
COMPLETED
PHASE4
ERAS Swallowing Rehabilitation in Elder Patients
NCT05999786
NOT_YET_RECRUITING
NA
Effectiveness of Intraoperative Neuromonitoring of External Branch of Superior Laryngeal Nerve During Thyroid Surgery
NCT03773120
TERMINATED
NA
Effectiveness of Intraoperative Neuromonitoring of External Branch of Superior Laryngeal Nerve in Thyroid Surgery
NCT06002984
RECRUITING
NA
Comparative Study of Transaxillary Robotic Thyroidectomy With MRND Versus Conventional Open Surgery in N1b PTC
NCT06623578
RECRUITING
NA
ST250 as a Therapeutic Option for Head & Neck Reconstruction
NCT06543823
RECRUITING
PHASE1/PHASE2
Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers
NCT07140757
RECRUITING
The Strategy of Implementation of the ERAS Protocol After Esophageal Surgery
NCT05311787
RECRUITING
NA
The Clinical Outcomes and Prediction of Thermal Ablation for Low-risk Papillary Thyroid Carcinoma
NCT06316895
RECRUITING
Interest of Cryotherapy or Cortisone Aerosol Therapy in Early Post-operative Swallowing Disorders Following Total Thyroidectomy
NCT02855866
COMPLETED
NA
Safety and Quality of Life of Three Treatment Strategies for Low-Risk Papillary Thyroid Microcarcinoma
NCT07249125
NOT_YET_RECRUITING
A Prospective, Open-label, Multicenter, Randomized Controlled Phase III Study of Prophylactic Central Neck Dissection in Low-risk Papillary Thyroid Cancer
NCT06082180
RECRUITING
PHASE3
Dysphagia After Thyroidectomy
NCT06296420
RECRUITING